|
|
||||||||
Biology of Reproduction, Vol 24, 315-322, Copyright © 1981 by Society for the Study of Reproduction
1 Departments of Pharmacology, Anatomy, and Obstetrics and Gynecology,
The University of Texas Health Science Center at San Antonio,
San Antonio, Texas 78284 In immature (30-35-day-old) mice, a single dose of
9-tetrahydrocannabinol (THC), the main
psychoactive constituent of marihuana, decreased plasma testosterone (T), LH, and FSH levels, but
the same dose of a nonpsychoactive component, cannabinol (CBN), had no effect. Chronic exposure to THC, CBN, or cannabidiol (CBD), beginning at 30 days of age through adulthood, influenced the endocrine responses to a sexually receptive female. Thus, weights of testes and seminal
vesicles were reduced in males from all cannabinoid-treated groups on the day after exposure to a
female, compared with treated males housed in all-male groups. Plasma FSH concentrations were
elevated in CBN-exposed mice, regardless of social experience, while plasma T levels were increased
after an encounter with a female in all but THC-treated males. Plasma LH levels and testicular
responsiveness to gonadotropins in vitro were reduced in THC-and CBN-treated mice exposed to a
female. In contrast, in THC- or CBN-treated males maintained in all-male groups, T production in
vitro was significantly elevated. Alterations in prostaglandin (PG) concentrations may mediate
these effects of cannabinoids and sexual encounter since production of PG in vitro by testis and
pituitary was reduced by exposing cannabinoid-treated males to female-related stimuli. In contrast,
sexual encounter increased PCF, but had no effect on PGE production by pituitary or testes
obtained from oil-treated controls. Both psychoactive and nonpsychoactive constitutents of
marihuana are capable of altering the function of the pituitary-gonadal axis and of influencing the
endocrine responsivity to female-related exteroceptive cues in male mice.
Note:
ACKNOWLEDGMENTS
We would like to thank M. P. Hogan and Dr. H.
Klemcke for their assistance, W. Friedrichs for prostaglandin incubations and RIA, and Dr. J. Pike, Upjohn
Co., for the gift of unlabeled prostaglandins. We would
also like to thank R. Hogg and Ayerst Co. for the
generous supply of LRF. We acknowledge the support
of the Radioimmunoassay Core Laboratory [grant P
30 HD 10202 and NIDA grant 1 RO1 DA 02342-01
(A.B.)]. We also thank C. Small for her excellent
preparation of this manuscript.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |